Molly Lamb
Concepts (398)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Development | 6 | 2025 | 481 | 1.600 |
Why?
| | Muscular Dystrophy, Duchenne | 6 | 2022 | 93 | 1.520 |
Why?
| | Rural Population | 18 | 2026 | 677 | 1.500 |
Why?
| | Head | 2 | 2025 | 125 | 1.450 |
Why?
| | Guatemala | 29 | 2026 | 349 | 1.440 |
Why?
| | Zika Virus Infection | 6 | 2024 | 174 | 1.240 |
Why?
| | Diet | 11 | 2024 | 1273 | 1.210 |
Why?
| | Autoimmunity | 8 | 2020 | 925 | 1.080 |
Why?
| | Islets of Langerhans | 6 | 2014 | 852 | 0.950 |
Why?
| | Zika Virus | 4 | 2024 | 137 | 0.920 |
Why?
| | Dengue | 2 | 2024 | 92 | 0.870 |
Why?
| | Influenza, Human | 7 | 2025 | 640 | 0.810 |
Why?
| | Diabetes Mellitus, Type 1 | 12 | 2020 | 3930 | 0.800 |
Why?
| | Infant | 38 | 2025 | 10114 | 0.760 |
Why?
| | Body Weight | 2 | 2018 | 968 | 0.760 |
Why?
| | Dengue Virus | 2 | 2024 | 62 | 0.750 |
Why?
| | Growth Disorders | 2 | 2023 | 89 | 0.740 |
Why?
| | Body Height | 2 | 2016 | 205 | 0.700 |
Why?
| | Child | 49 | 2026 | 22693 | 0.690 |
Why?
| | Child, Preschool | 38 | 2025 | 11913 | 0.660 |
Why?
| | School Teachers | 4 | 2026 | 28 | 0.550 |
Why?
| | Infant, Newborn | 18 | 2025 | 6460 | 0.540 |
Why?
| | Microcephaly | 4 | 2024 | 106 | 0.520 |
Why?
| | Child Nutritional Physiological Phenomena | 3 | 2015 | 102 | 0.500 |
Why?
| | Humans | 93 | 2026 | 146342 | 0.500 |
Why?
| | Dietary Carbohydrates | 2 | 2015 | 146 | 0.470 |
Why?
| | Pregnenediones | 1 | 2016 | 15 | 0.470 |
Why?
| | Prospective Studies | 18 | 2025 | 8123 | 0.470 |
Why?
| | Milk | 2 | 2014 | 117 | 0.450 |
Why?
| | HLA-DR Antigens | 2 | 2014 | 211 | 0.440 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 486 | 0.440 |
Why?
| | Carbohydrates | 1 | 2015 | 66 | 0.440 |
Why?
| | Carbonic Anhydrases | 2 | 2005 | 12 | 0.430 |
Why?
| | Prednisone | 1 | 2016 | 229 | 0.430 |
Why?
| | Culicidae | 2 | 2005 | 33 | 0.430 |
Why?
| | Male | 50 | 2026 | 73396 | 0.390 |
Why?
| | Immunoglobulin G | 4 | 2026 | 901 | 0.380 |
Why?
| | Eating | 2 | 2024 | 386 | 0.370 |
Why?
| | Body Mass Index | 8 | 2020 | 2458 | 0.370 |
Why?
| | Oryza | 2 | 2024 | 34 | 0.370 |
Why?
| | Female | 54 | 2026 | 79499 | 0.360 |
Why?
| | Disease Progression | 4 | 2015 | 2867 | 0.360 |
Why?
| | Infant Food | 2 | 2015 | 69 | 0.360 |
Why?
| | Multiplex Polymerase Chain Reaction | 2 | 2025 | 56 | 0.360 |
Why?
| | Developing Countries | 3 | 2025 | 312 | 0.360 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2025 | 141 | 0.360 |
Why?
| | Viruses | 3 | 2023 | 165 | 0.350 |
Why?
| | Cross-Sectional Studies | 10 | 2025 | 5899 | 0.350 |
Why?
| | Sarcoma, Kaposi | 2 | 2023 | 83 | 0.350 |
Why?
| | Seroepidemiologic Studies | 5 | 2023 | 171 | 0.340 |
Why?
| | Cohort Studies | 10 | 2025 | 6077 | 0.340 |
Why?
| | Glucocorticoids | 1 | 2016 | 536 | 0.340 |
Why?
| | Antibodies, Viral | 7 | 2026 | 689 | 0.340 |
Why?
| | Global Health | 2 | 2025 | 403 | 0.330 |
Why?
| | Audiovisual Aids | 1 | 2010 | 11 | 0.330 |
Why?
| | Sexual Maturation | 1 | 2010 | 49 | 0.320 |
Why?
| | Hyperlipidemias | 1 | 2011 | 120 | 0.320 |
Why?
| | Hypercholesterolemia | 1 | 2011 | 95 | 0.320 |
Why?
| | Pregnancy | 12 | 2024 | 7230 | 0.300 |
Why?
| | Virus Diseases | 2 | 2022 | 219 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2025 | 1408 | 0.290 |
Why?
| | Overweight | 3 | 2019 | 614 | 0.290 |
Why?
| | Self Concept | 1 | 2010 | 257 | 0.280 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2005 | 14 | 0.280 |
Why?
| | Risk Factors | 13 | 2025 | 10921 | 0.280 |
Why?
| | Vaccination | 4 | 2026 | 1449 | 0.280 |
Why?
| | Meningitis, Bacterial | 2 | 2022 | 52 | 0.280 |
Why?
| | Glycemic Index | 1 | 2008 | 26 | 0.280 |
Why?
| | Adolescent | 21 | 2025 | 22557 | 0.280 |
Why?
| | Autoantibodies | 5 | 2020 | 1500 | 0.270 |
Why?
| | Delivery, Obstetric | 2 | 2019 | 164 | 0.270 |
Why?
| | Obesity | 5 | 2015 | 3131 | 0.260 |
Why?
| | Caliciviridae Infections | 2 | 2018 | 18 | 0.260 |
Why?
| | Norovirus | 2 | 2018 | 22 | 0.260 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 6073 | 0.260 |
Why?
| | Body Composition | 1 | 2011 | 689 | 0.250 |
Why?
| | Respiratory Tract Infections | 2 | 2022 | 403 | 0.250 |
Why?
| | Viral Vaccines | 2 | 2018 | 107 | 0.250 |
Why?
| | Psychology, Child | 1 | 2007 | 35 | 0.250 |
Why?
| | Caregivers | 3 | 2021 | 1080 | 0.250 |
Why?
| | Adipose Tissue | 1 | 2011 | 642 | 0.250 |
Why?
| | Gastroenteritis | 2 | 2017 | 63 | 0.250 |
Why?
| | Adult | 23 | 2026 | 41087 | 0.240 |
Why?
| | Genotype | 4 | 2015 | 1879 | 0.240 |
Why?
| | Interviews as Topic | 1 | 2010 | 930 | 0.240 |
Why?
| | Lipids | 2 | 2011 | 714 | 0.240 |
Why?
| | Mental Disorders | 2 | 2026 | 1148 | 0.240 |
Why?
| | Young Adult | 17 | 2026 | 14330 | 0.240 |
Why?
| | Herpesvirus 8, Human | 2 | 2023 | 67 | 0.240 |
Why?
| | Virus Shedding | 1 | 2026 | 54 | 0.230 |
Why?
| | Mental Health Services | 2 | 2021 | 450 | 0.230 |
Why?
| | Blood Culture | 1 | 2025 | 27 | 0.220 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2025 | 83 | 0.220 |
Why?
| | Schools | 4 | 2023 | 436 | 0.220 |
Why?
| | Gastrointestinal Tract | 2 | 2019 | 203 | 0.220 |
Why?
| | Ectoparasitic Infestations | 1 | 2024 | 5 | 0.220 |
Why?
| | Animals, Domestic | 1 | 2024 | 17 | 0.220 |
Why?
| | Masks | 2 | 2022 | 70 | 0.220 |
Why?
| | Nasopharynx | 1 | 2025 | 72 | 0.220 |
Why?
| | Rural Health Services | 1 | 2026 | 139 | 0.210 |
Why?
| | Mental Health | 3 | 2026 | 779 | 0.210 |
Why?
| | Digestive System | 1 | 2004 | 29 | 0.200 |
Why?
| | Niacin | 1 | 2024 | 16 | 0.200 |
Why?
| | Income | 1 | 2025 | 206 | 0.200 |
Why?
| | Culex | 1 | 2023 | 14 | 0.200 |
Why?
| | Psychotherapy | 1 | 2025 | 183 | 0.200 |
Why?
| | Educational Personnel | 1 | 2023 | 11 | 0.200 |
Why?
| | Coinfection | 2 | 2022 | 143 | 0.190 |
Why?
| | Saliva | 1 | 2025 | 256 | 0.190 |
Why?
| | HIV Seropositivity | 1 | 2023 | 118 | 0.190 |
Why?
| | Antimicrobial Stewardship | 1 | 2025 | 136 | 0.190 |
Why?
| | Aedes | 1 | 2023 | 67 | 0.190 |
Why?
| | Bacteremia | 1 | 2025 | 218 | 0.190 |
Why?
| | Public Health | 2 | 2026 | 574 | 0.190 |
Why?
| | Cross Reactions | 1 | 2022 | 130 | 0.180 |
Why?
| | Metapneumovirus | 1 | 2022 | 16 | 0.180 |
Why?
| | Diarrhea | 2 | 2023 | 190 | 0.180 |
Why?
| | Family Characteristics | 5 | 2026 | 203 | 0.180 |
Why?
| | Cephalometry | 1 | 2022 | 30 | 0.180 |
Why?
| | Anthropometry | 1 | 2022 | 204 | 0.170 |
Why?
| | Erythrocyte Membrane | 2 | 2015 | 55 | 0.170 |
Why?
| | Prevalence | 8 | 2021 | 2861 | 0.170 |
Why?
| | Parents | 3 | 2023 | 1394 | 0.170 |
Why?
| | Family Health | 2 | 2015 | 194 | 0.170 |
Why?
| | Sexually Transmitted Diseases, Viral | 1 | 2021 | 11 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2024 | 239 | 0.170 |
Why?
| | Lead Poisoning | 1 | 2021 | 18 | 0.160 |
Why?
| | Meningitis | 1 | 2022 | 80 | 0.160 |
Why?
| | Pandemics | 3 | 2025 | 1707 | 0.160 |
Why?
| | Health Literacy | 1 | 2023 | 183 | 0.160 |
Why?
| | Cesarean Section | 2 | 2019 | 230 | 0.160 |
Why?
| | Arsenic | 1 | 2021 | 66 | 0.160 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1331 | 0.160 |
Why?
| | Socioeconomic Factors | 1 | 2025 | 1327 | 0.160 |
Why?
| | Motivation | 1 | 2025 | 605 | 0.160 |
Why?
| | Emergency Responders | 1 | 2021 | 38 | 0.160 |
Why?
| | Birth Intervals | 1 | 2020 | 23 | 0.160 |
Why?
| | Malaria | 1 | 2021 | 73 | 0.160 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 104 | 0.160 |
Why?
| | Midwifery | 1 | 2022 | 70 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 846 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2015 | 145 | 0.160 |
Why?
| | Lysine | 1 | 2022 | 303 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2022 | 100 | 0.160 |
Why?
| | Specimen Handling | 1 | 2022 | 178 | 0.160 |
Why?
| | Endpoint Determination | 1 | 2020 | 84 | 0.150 |
Why?
| | Cesarean Section, Repeat | 1 | 2019 | 11 | 0.150 |
Why?
| | Regression Analysis | 1 | 2022 | 999 | 0.150 |
Why?
| | India | 3 | 2026 | 213 | 0.150 |
Why?
| | Vaginal Birth after Cesarean | 1 | 2019 | 27 | 0.150 |
Why?
| | Age of Onset | 4 | 2022 | 558 | 0.150 |
Why?
| | Language Tests | 1 | 2019 | 24 | 0.150 |
Why?
| | Refugees | 1 | 2021 | 84 | 0.150 |
Why?
| | Breast Feeding | 4 | 2015 | 447 | 0.150 |
Why?
| | Population Surveillance | 2 | 2026 | 481 | 0.150 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5439 | 0.150 |
Why?
| | Language Development Disorders | 1 | 2019 | 40 | 0.140 |
Why?
| | Sexual Partners | 1 | 2021 | 195 | 0.140 |
Why?
| | Dietary Proteins | 2 | 2013 | 135 | 0.140 |
Why?
| | Motor Skills | 1 | 2020 | 103 | 0.140 |
Why?
| | Social Class | 2 | 2010 | 260 | 0.140 |
Why?
| | Adolescent Health | 1 | 2019 | 38 | 0.140 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 29 | 0.140 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2021 | 293 | 0.140 |
Why?
| | Arbovirus Infections | 1 | 2018 | 20 | 0.140 |
Why?
| | Sensitivity and Specificity | 5 | 2025 | 1998 | 0.140 |
Why?
| | Sexual Behavior | 2 | 2021 | 490 | 0.140 |
Why?
| | Public Health Surveillance | 1 | 2018 | 84 | 0.140 |
Why?
| | HLA-DQ beta-Chains | 2 | 2015 | 58 | 0.130 |
Why?
| | HLA-DR4 Antigen | 2 | 2015 | 74 | 0.130 |
Why?
| | Linear Models | 3 | 2023 | 857 | 0.130 |
Why?
| | HLA-DR3 Antigen | 2 | 2015 | 76 | 0.130 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 438 | 0.130 |
Why?
| | Vaccines | 1 | 2023 | 389 | 0.130 |
Why?
| | Epilepsy | 1 | 2022 | 400 | 0.130 |
Why?
| | Sentinel Surveillance | 1 | 2017 | 48 | 0.130 |
Why?
| | Emergency Service, Hospital | 4 | 2022 | 2363 | 0.130 |
Why?
| | Medicaid | 1 | 2021 | 477 | 0.130 |
Why?
| | Celiac Disease | 1 | 2020 | 285 | 0.130 |
Why?
| | Sex Factors | 4 | 2010 | 2107 | 0.120 |
Why?
| | Cell Phone | 1 | 2017 | 83 | 0.120 |
Why?
| | Biomarkers | 3 | 2025 | 4340 | 0.120 |
Why?
| | Micronutrients | 2 | 2007 | 102 | 0.120 |
Why?
| | Urban Population | 1 | 2019 | 497 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3416 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 544 | 0.120 |
Why?
| | Fever | 1 | 2017 | 322 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2017 | 185 | 0.110 |
Why?
| | Health Resources | 1 | 2017 | 131 | 0.110 |
Why?
| | Learning | 1 | 2020 | 446 | 0.110 |
Why?
| | Feeding Methods | 1 | 2015 | 5 | 0.110 |
Why?
| | F2-Isoprostanes | 1 | 2015 | 21 | 0.110 |
Why?
| | Models, Psychological | 1 | 2017 | 290 | 0.110 |
Why?
| | Methazolamide | 2 | 2005 | 5 | 0.110 |
Why?
| | Animals | 9 | 2026 | 38107 | 0.110 |
Why?
| | Oxygen Isotopes | 2 | 2005 | 24 | 0.110 |
Why?
| | Acetazolamide | 2 | 2005 | 26 | 0.110 |
Why?
| | Mobile Applications | 1 | 2017 | 196 | 0.110 |
Why?
| | Histocytochemistry | 2 | 2005 | 77 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2015 | 56 | 0.110 |
Why?
| | Energy Intake | 2 | 2008 | 507 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 529 | 0.110 |
Why?
| | District of Columbia | 2 | 2012 | 37 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1942 | 0.100 |
Why?
| | Food Supply | 1 | 2015 | 94 | 0.100 |
Why?
| | Chickens | 2 | 2024 | 169 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2019 | 486 | 0.100 |
Why?
| | Age Factors | 5 | 2015 | 3347 | 0.100 |
Why?
| | Walking | 1 | 2018 | 546 | 0.100 |
Why?
| | Species Specificity | 2 | 2005 | 543 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2005 | 534 | 0.100 |
Why?
| | United States | 9 | 2021 | 16136 | 0.100 |
Why?
| | Health Behavior | 1 | 2019 | 802 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2021 | 3647 | 0.090 |
Why?
| | Social Support | 1 | 2017 | 646 | 0.090 |
Why?
| | Seroconversion | 2 | 2023 | 48 | 0.090 |
Why?
| | Kenya | 2 | 2023 | 129 | 0.090 |
Why?
| | Contact Tracing | 1 | 2012 | 26 | 0.090 |
Why?
| | Psychometrics | 3 | 2021 | 712 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 339 | 0.090 |
Why?
| | Transportation | 1 | 2012 | 54 | 0.090 |
Why?
| | Personal Protective Equipment | 2 | 2022 | 59 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2022 | 0.090 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 881 | 0.090 |
Why?
| | Mass Spectrometry | 2 | 2005 | 729 | 0.080 |
Why?
| | Insulin | 2 | 2015 | 2525 | 0.080 |
Why?
| | Cattle | 1 | 2014 | 940 | 0.080 |
Why?
| | Quality Improvement | 4 | 2022 | 1354 | 0.080 |
Why?
| | Area Under Curve | 2 | 2009 | 335 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2012 | 127 | 0.080 |
Why?
| | Acute Disease | 3 | 2019 | 1038 | 0.080 |
Why?
| | Child Behavior | 2 | 2026 | 234 | 0.080 |
Why?
| | HLA Antigens | 2 | 2013 | 241 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 589 | 0.080 |
Why?
| | Nutrition Surveys | 4 | 2015 | 270 | 0.080 |
Why?
| | Middle Aged | 9 | 2026 | 36619 | 0.080 |
Why?
| | ROC Curve | 2 | 2009 | 617 | 0.070 |
Why?
| | Fetal Weight | 1 | 2009 | 53 | 0.070 |
Why?
| | Pilot Projects | 2 | 2025 | 1888 | 0.070 |
Why?
| | Chikungunya Fever | 2 | 2021 | 82 | 0.070 |
Why?
| | Quality of Life | 2 | 2022 | 3200 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 325 | 0.070 |
Why?
| | Stress, Psychological | 1 | 2017 | 1171 | 0.070 |
Why?
| | Colorado | 3 | 2026 | 4595 | 0.070 |
Why?
| | Solanum tuberosum | 1 | 2008 | 8 | 0.070 |
Why?
| | Retrospective Studies | 6 | 2022 | 17438 | 0.070 |
Why?
| | Edible Grain | 1 | 2008 | 45 | 0.070 |
Why?
| | HIV Infections | 1 | 2023 | 3215 | 0.070 |
Why?
| | Bias | 1 | 2009 | 197 | 0.070 |
Why?
| | Pregnancy in Diabetics | 1 | 2009 | 123 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 692 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2009 | 178 | 0.060 |
Why?
| | Radiographic Image Enhancement | 1 | 2007 | 57 | 0.060 |
Why?
| | Self Disclosure | 1 | 2007 | 62 | 0.060 |
Why?
| | Vegetables | 1 | 2008 | 159 | 0.060 |
Why?
| | Birth Weight | 1 | 2009 | 521 | 0.060 |
Why?
| | Longitudinal Studies | 4 | 2018 | 3017 | 0.060 |
Why?
| | Vitamins | 2 | 2024 | 183 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2010 | 1135 | 0.060 |
Why?
| | Gestational Age | 1 | 2009 | 990 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2007 | 426 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1543 | 0.060 |
Why?
| | Glucagon-Like Peptide 2 | 1 | 2025 | 7 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2240 | 0.060 |
Why?
| | Weight Gain | 1 | 2009 | 562 | 0.060 |
Why?
| | Mammography | 1 | 2007 | 175 | 0.060 |
Why?
| | Risk | 2 | 2021 | 920 | 0.060 |
Why?
| | Students | 2 | 2023 | 649 | 0.060 |
Why?
| | West Nile Fever | 1 | 2026 | 57 | 0.060 |
Why?
| | Influenza B virus | 1 | 2025 | 47 | 0.060 |
Why?
| | Anaplasma | 1 | 2024 | 3 | 0.050 |
Why?
| | Ehrlichia | 1 | 2024 | 4 | 0.050 |
Why?
| | Bartonella | 1 | 2024 | 8 | 0.050 |
Why?
| | Rickettsia | 1 | 2024 | 11 | 0.050 |
Why?
| | Siphonaptera | 1 | 2024 | 14 | 0.050 |
Why?
| | Mental Recall | 1 | 2007 | 226 | 0.050 |
Why?
| | Dietary Fats | 1 | 2007 | 307 | 0.050 |
Why?
| | Ticks | 1 | 2024 | 30 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2013 | 2488 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1149 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 2007 | 227 | 0.050 |
Why?
| | Nutritional Status | 1 | 2007 | 346 | 0.050 |
Why?
| | Cats | 1 | 2024 | 226 | 0.050 |
Why?
| | Influenza A virus | 1 | 2025 | 120 | 0.050 |
Why?
| | Prognosis | 1 | 2013 | 4351 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 738 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2026 | 348 | 0.050 |
Why?
| | Magnesium | 1 | 2024 | 155 | 0.050 |
Why?
| | Mosquito Vectors | 1 | 2023 | 32 | 0.050 |
Why?
| | Dogs | 1 | 2024 | 517 | 0.050 |
Why?
| | Dog Diseases | 1 | 2024 | 140 | 0.050 |
Why?
| | Larva | 1 | 2004 | 242 | 0.050 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2009 | 665 | 0.050 |
Why?
| | Databases, Factual | 2 | 2019 | 1493 | 0.050 |
Why?
| | Pyridoxine | 1 | 2022 | 37 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2023 | 8391 | 0.050 |
Why?
| | Vomiting | 1 | 2023 | 131 | 0.050 |
Why?
| | Vital Signs | 1 | 2022 | 39 | 0.050 |
Why?
| | Cough | 1 | 2023 | 123 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 133 | 0.040 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2022 | 98 | 0.040 |
Why?
| | Swine | 1 | 2024 | 821 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 288 | 0.040 |
Why?
| | World Health Organization | 1 | 2022 | 104 | 0.040 |
Why?
| | Fermentation | 1 | 2021 | 31 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 321 | 0.040 |
Why?
| | Food Contamination | 1 | 2021 | 36 | 0.040 |
Why?
| | Methylene Blue | 1 | 2021 | 24 | 0.040 |
Why?
| | Phenotype | 2 | 2022 | 3206 | 0.040 |
Why?
| | Equipment Reuse | 1 | 2021 | 18 | 0.040 |
Why?
| | Decontamination | 1 | 2021 | 28 | 0.040 |
Why?
| | Attitude | 1 | 2023 | 253 | 0.040 |
Why?
| | Immunization | 1 | 2023 | 376 | 0.040 |
Why?
| | Hot Temperature | 1 | 2024 | 396 | 0.040 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2021 | 50 | 0.040 |
Why?
| | Hospitalization | 2 | 2022 | 2475 | 0.040 |
Why?
| | Telephone | 1 | 2021 | 175 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 129 | 0.040 |
Why?
| | Brazil | 1 | 2021 | 179 | 0.040 |
Why?
| | Lead | 1 | 2021 | 71 | 0.040 |
Why?
| | Diet Surveys | 2 | 2013 | 89 | 0.040 |
Why?
| | Immunoglobulin M | 1 | 2022 | 284 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 496 | 0.040 |
Why?
| | Mass Screening | 1 | 2009 | 1307 | 0.040 |
Why?
| | Absenteeism | 1 | 2020 | 51 | 0.040 |
Why?
| | Translations | 1 | 2020 | 14 | 0.040 |
Why?
| | Chikungunya virus | 1 | 2021 | 81 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 179 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2026 | 1763 | 0.040 |
Why?
| | Respiratory Tract Diseases | 1 | 2021 | 178 | 0.040 |
Why?
| | Parity | 1 | 2019 | 113 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 310 | 0.040 |
Why?
| | Child Language | 1 | 2019 | 21 | 0.040 |
Why?
| | Translating | 1 | 2019 | 46 | 0.040 |
Why?
| | Triage | 1 | 2021 | 243 | 0.040 |
Why?
| | Rural Health | 1 | 2019 | 87 | 0.040 |
Why?
| | Parasites | 1 | 2019 | 44 | 0.040 |
Why?
| | Dengue Vaccines | 1 | 2018 | 11 | 0.040 |
Why?
| | Arboviruses | 1 | 2018 | 14 | 0.040 |
Why?
| | Culturally Competent Care | 1 | 2019 | 66 | 0.030 |
Why?
| | Thinness | 1 | 2019 | 100 | 0.030 |
Why?
| | Seasons | 1 | 2021 | 540 | 0.030 |
Why?
| | Pregnancy in Adolescence | 1 | 2019 | 78 | 0.030 |
Why?
| | RNA, Viral | 1 | 2022 | 693 | 0.030 |
Why?
| | Blood Glucose | 1 | 2008 | 2360 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 517 | 0.030 |
Why?
| | Proteins | 1 | 2004 | 1022 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 117 | 0.030 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 234 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2019 | 178 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1734 | 0.030 |
Why?
| | Choice Behavior | 1 | 2019 | 179 | 0.030 |
Why?
| | Child Health | 1 | 2019 | 153 | 0.030 |
Why?
| | Mothers | 1 | 2023 | 772 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 469 | 0.030 |
Why?
| | Medical Records | 1 | 2018 | 193 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 511 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 503 | 0.030 |
Why?
| | Internal-External Control | 1 | 2017 | 73 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1053 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2021 | 628 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2113 | 0.030 |
Why?
| | Research Design | 1 | 2023 | 1143 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2126 | 0.030 |
Why?
| | Risk-Taking | 1 | 2019 | 321 | 0.030 |
Why?
| | Life Change Events | 1 | 2017 | 144 | 0.030 |
Why?
| | Aged | 3 | 2025 | 26432 | 0.030 |
Why?
| | Telemedicine | 1 | 2025 | 966 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 97 | 0.030 |
Why?
| | Data Collection | 1 | 2018 | 650 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 706 | 0.030 |
Why?
| | Cities | 1 | 2015 | 140 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2418 | 0.030 |
Why?
| | Cognition | 1 | 2022 | 1292 | 0.030 |
Why?
| | Bacteria | 1 | 2019 | 766 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7109 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 340 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2921 | 0.020 |
Why?
| | Health Promotion | 1 | 2019 | 786 | 0.020 |
Why?
| | Automobiles | 1 | 2012 | 18 | 0.020 |
Why?
| | Virginia | 1 | 2012 | 57 | 0.020 |
Why?
| | Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
| | Maryland | 1 | 2012 | 67 | 0.020 |
Why?
| | Survival Analysis | 1 | 2015 | 1378 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 379 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1665 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3712 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 2017 | 721 | 0.020 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 96 | 0.020 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2007 | 47 | 0.020 |
Why?
| | Environmental Exposure | 1 | 2012 | 578 | 0.020 |
Why?
| | Carotenoids | 1 | 2007 | 47 | 0.020 |
Why?
| | Research Personnel | 1 | 2009 | 190 | 0.020 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2007 | 159 | 0.010 |
Why?
| | Models, Statistical | 1 | 2009 | 669 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2009 | 478 | 0.010 |
Why?
| | Early Detection of Cancer | 1 | 2009 | 506 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2007 | 1064 | 0.010 |
Why?
|
|
Lamb's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|